Equities

Beijing Tongrentang Co Ltd

600085:SHH

Beijing Tongrentang Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)42.54
  • Today's Change-0.40 / -0.93%
  • Shares traded17.40m
  • 1 Year change-16.21%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments12,01011,6249,886
Total Receivables, Net1,7101,9771,887
Total Inventory9,3406,6946,169
Prepaid expenses144161186
Other current assets, total15710345
Total current assets23,36120,55918,174
Property, plant & equipment, net5,5335,2935,745
Goodwill, net464541
Intangibles, net755746736
Long term investments262819
Note receivable - long term0.551.131.95
Other long term assets4.6956--
Total assets30,08927,05425,073
LIABILITIES
Accounts payable4,2763,4473,193
Accrued expenses672408527
Notes payable/short-term debt7543531,298
Current portion long-term debt/capital leases523486524
Other current liabilities, total9371,641762
Total current liabilities7,1626,3366,302
Total long term debt2,4952,0831,881
Total debt3,7732,9223,703
Deferred income tax7.948.828.13
Minority interest7,1996,6536,039
Other liabilities, total167163208
Total liabilities17,03115,24414,439
SHAREHOLDERS EQUITY
Common stock1,3711,3711,371
Additional paid-in capital2,0012,0061,993
Retained earnings (accumulated deficit)9,5748,3447,313
Treasury stock - common------
Unrealized gain (loss)(2.78)--(3.8)
Other equity, total11489(40)
Total equity13,05811,81010,634
Total liabilities & shareholders' equity30,08927,05425,073
Total common shares outstanding1,3711,3711,371
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.